By Lucy Craymer WELLINGTON--Rio Tinto PLC (RIO) has declined the New Zealand government's help in negotiations over an energy supply contract...
0511 GMT [Dow Jones] The NZX-50 adds 0.7% to 30 points to 4244.21 as investors digest corporate results. Contact Energy (CEN.NZ) rises 3.4% to...
2058 GMT [Dow Jones] The NZX-50 is likely to be relatively flat in the absence of cues from offshore markets, says Hamilton Hindin Greene broker...
NEW YORK, Sept. 7 /PRNewswire/ -- Pershing Square Capital Management, L.P. announced today that it is sending the following letter to Ceridian...
Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices NEW YORK, Dec. 10 /PRNewswire/...
RNS Number:6678U CeNeS Pharmaceuticals PLC 27 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The Company...
RNS Number:6672U CeNeS Pharmaceuticals PLC 27 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The Company...
RNS Number:4651U CeNeS Pharmaceuticals PLC 21 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The Company was...
RNS Number:4413U CeNeS Pharmaceuticals PLC 20 January 2004 CeNeS Pharmaceuticals plc Additional Listing Application has been made for...
RNS Number:3209U CeNeS Pharmaceuticals PLC 16 January 2004 CENES PHARMACEUTICALS PLC ("CeNeS" or "the Company") Notice of Extraordinary...
RNS Number:2346U CeNeS Pharmaceuticals PLC 14 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The...
The Company received notification today that a client of ISIS Asset Management plc, Active Capital Trust, following the disposal of 4,500,000...
Cambridge, UK, 12 January 2004 - CeNeS Pharmaceuticals plc (LSE: CEN) ("CeNeS" or "the Company"), is pleased to announce the appointment of Piper...
RNS Number:9745T CeNeS Pharmaceuticals PLC 08 January 2004 CeNeS announces appointment of Alan Smith as non-executive director...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads